Xeligekimab | Interleukin Related interleukin-related.com

Product Name :
Xeligekimab

Search keywords :
Xeligekimab

drugId :
null

Target Vo:
Interleukin 17A

Target Vo Short Name :
IL17A

Moa_Name:
Interleukin 17A inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Genrix (Shanghai) Biopharmaceutical Co Ltd

Active Company_Name :
Chongqing Zhixiang Jintai Biopharmaceutical Co Ltd

Active Indication_Name:
Spondylarthritis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
NDA/BLA

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IL-1 beta Antibody (YA345)
GPX1 Antibody
SIRT5 Antibody: SIRT5 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to SIRT5. It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts